Securities code: 002795 securities abbreviation: Yorhe Fluid Intelligent Control Co.Ltd(002795) Announcement No.: 2022-011 Yorhe Fluid Intelligent Control Co.Ltd(002795)
Announcement on the completion of the transfer of 37.2139% equity of the wholly-owned subsidiary’s acquisition of Xi’an Medical Cancer Hospital Co., Ltd
The company and all members of its board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
Yorhe Fluid Intelligent Control Co.Ltd(002795) (hereinafter referred to as “the company”) has recently completed the asset transfer procedures and relevant industrial and commercial registration for the acquisition of 37.2139% equity of the target Xi’an Medical Cancer Hospital Co., Ltd. (hereinafter referred to as “Xi’an Medical”), and obtained a new business license issued by the administrative examination and approval service bureau of Lianhu District, Xi’an city. After the industrial and commercial change, Chengdu yonghecheng Medical Technology Co., Ltd., a wholly-owned subsidiary of the company, holds 57% of the equity of Xi’an Medical. The relevant industrial and commercial registration information after the change is as follows:
Company name: Xi’an Medical tumor hospital Co., Ltd
Unified social credit Code: 91610104ma6uth0p45
Enterprise type: other limited liability companies
Legal representative: Deng Lili
Registered capital: seventy four million eight hundred thousand yuan
Date of establishment: April 10, 2018
Address: Yong’an building, No. 60, west section of Second Ring South Road, Lianhu District, Xi’an City
Business scope: for profit medical institutions. (for projects subject to approval according to law, business activities can be carried out only after approval by relevant departments).
It is hereby announced.
Yorhe Fluid Intelligent Control Co.Ltd(002795) board of directors February 7, 2022
